|
|
|
Insider
Information: |
Schenkein David P |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
174,790 |
|
Indirect Shares
|
417,826 |
|
|
Direct
Value |
$6,163,557 |
|
|
Indirect Value
|
$16,623,289 |
|
|
Total
Shares |
592,616 |
|
|
Total
Value |
$22,786,845 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
Percentage
Gain/Loss : |
0.0%
|
118.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2024-02-27 |
122,854 |
2024-02-27 |
349,854 |
Premium* |
|
Foundation Medicine, Inc. |
FMI |
Director |
2016-06-16 |
23,326 |
2016-06-16 |
10,508 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
|
2020-06-18 |
6,832 |
2014-12-19 |
0 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
2024-05-31 |
57,464 |
Premium* |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
282 |
2023-09-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-09-18 |
4 |
OE |
$0.30 |
$10,588 |
D/D |
35,000 |
35,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-10-02 |
4 |
OE |
$0.30 |
$1,815 |
D/D |
6,000 |
6,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-10-04 |
4 |
OE |
$0.30 |
$24,200 |
D/D |
80,000 |
80,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-11-01 |
4 |
OE |
$0.30 |
$1,815 |
D/D |
6,000 |
6,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2017-12-01 |
4 |
OE |
$0.30 |
$1,815 |
D/D |
6,000 |
6,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-16 |
4 |
OE |
$0.30 |
$16,033 |
D/D |
53,000 |
53,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-23 |
4 |
OE |
$0.30 |
$9,945 |
D/D |
32,875 |
32,875 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
OE |
$0.30 |
$6 |
D/D |
20 |
20 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-24 |
4 |
OE |
$0.30 |
$4,094 |
D/D |
13,533 |
13,533 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-01-26 |
4 |
OE |
$0.30 |
$7,131 |
D/D |
23,572 |
23,572 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-02-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-03-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-04-02 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-01 |
4 |
OE |
$0.30 |
$3,933 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-23 |
4 |
OE |
$0.30 |
$14,936 |
D/D |
49,374 |
49,374 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-05-30 |
4 |
OE |
$0.30 |
$17,675 |
D/D |
45,626 |
45,626 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-06-01 |
4 |
OE |
$0.47 |
$6,280 |
D/D |
13,000 |
13,000 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Chief Executive Officer |
|
2018-09-05 |
4 |
OE |
$2.34 |
$249,028 |
D/D |
75,119 |
75,119 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-01-17 |
4 |
OE |
$9.05 |
$181,000 |
D/D |
20,000 |
137,879 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-01-30 |
4 |
OE |
$9.05 |
$181,000 |
D/D |
20,000 |
137,879 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-02-13 |
4 |
OE |
$9.05 |
$181,000 |
D/D |
20,000 |
137,879 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-02-27 |
4 |
OE |
$9.05 |
$181,000 |
D/D |
20,000 |
137,879 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-03-27 |
4 |
OE |
$9.05 |
$181,000 |
D/D |
20,000 |
137,879 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-04-03 |
4 |
OE |
$9.05 |
$148,085 |
D/D |
16,363 |
134,242 |
0 |
- |
|
FMI |
Foundation Medicine, Inc. |
Director |
|
2016-06-16 |
4 |
A |
$19.93 |
$240,655 |
D/D |
12,075 |
23,326 |
0 |
- |
|
154 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|